Rodeo Therapeutics
Seattle, US · Founded 2017 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
AX
Asish XavierDirector
SG
Steve GillisDirector
TL
Thong LeExecutive Officer, Director, Promoter
DS
David SchubertExecutive Officer, Promoter
SM
Sanford MarkowitzDirector
JS
James SullivanDirector
LR
Lindsay RayleExecutive Officer, Promoter
JM
Joel MarcusDirector
TY
Tadataka YamadaDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$8.9MraisedApr 2020 · 9 investors · BiotechnologyRule 506(b)
▶$8.9MraisedApr 2020 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kendall MohlerExecutive Officer
- Margarita ChavezDirector
- Katie HewittDirector
- Thong LeExecutive Officer, Director, Promoter
- Tadataka YamadaDirector
- Asish XavierDirector
- Suzanne RettenmierExecutive Officer
- Sanford MarkowitzDirector
- Ian HowesExecutive Officer
- Steve GillisDirector
- Offering amount
- $8.9M
- Amount sold
- $8.9M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$5.4MraisedAug 2017 · 8 investors · BiotechnologyRule 506(b)
▶$5.4MraisedAug 2017 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Asish XavierDirector
- Steve GillisDirector
- Thong LeExecutive Officer, Director, Promoter
- David SchubertExecutive Officer, Promoter
- Sanford MarkowitzDirector
- James SullivanDirector
- Lindsay RayleExecutive Officer, Promoter
- Joel MarcusDirector
- Tadataka YamadaDirector
- Offering amount
- $5.9M
- Amount sold
- $5.4M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.